🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the combination of the chemotherapy dr...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2010-09
Trial ID
NCT01106872
Treatments Being Tested
This study will assess the safety and pharmacokinetics of adding dulanermin...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT00671372
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Institut Bergonie
Start Date
2007-01-23
Trial ID
NCT00467142
Treatments Being Tested
Approximately 20-50% of patients with colorectal cancer (CRC) develop dista...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-05-10
Trial ID
NCT07604909
Treatments Being Tested
This was the cross-sectional study to assess the period prevalence of IOI i...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-07-15
Trial ID
NCT05146687
Treatments Being Tested
Bevacizumab plus capecitabin is a standard maintenance treatment following ...
Status
Withdrawn
Location
Rongbo Lin
Start Date
2018-11
Trial ID
NCT03708536
Treatments Being Tested
An open-label, multicenter, phase II clinical study to evaluate the efficac...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06783647
The correlation between the values of angiogenesis-related growth factors i...
Status
Completed
Location
EPS Corporation
Start Date
2013-05
Trial ID
NCT01834014
Hepatocellular carcinoma (HCC) is a common global malignancy. In China, the...
Status
Active Not Recruiting
Location
Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, Heilongjiang Province, China
Start Date
2026-05-13
Trial ID
NCT07645209
Treatments Being Tested
The purpose of this study is to test the safety of certolizumab when it is ...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge
Start Date
2014-04-15
Trial ID
NCT02120807
Treatments Being Tested